Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-01

Clinical Trial Update: Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the efficacy of esmolol in identifying cardiovascular disorders in patients with cirrhosis and diabetes mellitus, including contex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esmolol (esmolol)

Snippet

Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER) | Conditions: Cirrhosis, Diabetes Mellitus | Phase 3 | Status: RECRUITING